Table 1. Baseline characteristics of study participants with discordant RDT results.
Variables | 2014 (n = 361) |
2015 (n = 582) | 2016 (n = 424) |
Total (N = 1367) |
---|---|---|---|---|
n(%) | n(%) | n(%) | n(%) | |
Sex* | ||||
Male | 266(73.7) | 431(74.1) | 298(70.3) | 995(72.8) |
Female | 95(26.3) | 151(25.90 | 126(29.7) | 372(27.2) |
Patients' age groups(years)* | ||||
<5 | 29(8.0) | 50(8.6) | 34(8.0) | 113(8.3) |
5–17 | 26(7.2) | 40(6.9) | 25(6.0) | 91(6.7) |
18–25 | 253(70.1) | 405(69.6) | 314(74.1) | 972(71.1) |
>25+ | 53(14.7) | 87(14.9) | 51(12.0) | 191(14.0) |
Health facilities* | ||||
Bulombora | 104(28.8) | 17(2.9) | 9(1.1) | 130(9.5) |
Chita | 0(0.0) | 80(13.7) | 64(15.1) | 144(10.5) |
Maramba | 78(21.6) | 228(39.2) | 96(22.6) | 402(29.4) |
Mgambo | 60(16.76) | 116(19.9) | 144(33.9) | 320(23.4) |
Msange | 0(0.0) | 35(6.0) | 52(12.3) | 87(6.4) |
Ruvu | 71(19.7) | 106(18.2) | 34(8.0) | 211(15.4) |
Rwamkoma | 48(13.3) | 0(0.0) | 25(6.0) | 73(5.3) |
Type of discordant results* | ||||
False negative results | 245(67.9) | 346(59.5) | 231(54.5) | 822(60.1) |
False positive results | 116(32.1) | 236(40.5) | 193(45.5) | 545(39.9) |
Patients eligible for follow-up** | ||||
Eligible | 200(55.4) | 282(48.4) | 217(51.2) | 699(51.1) |
Not eligible | 161(44.6) | 300(51.6) | 207(48.8) | 668(48.9) |
* p≤0.001
** p≥0.001